{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-096648","form_type":"8-K","ticker":"MIST","cik":"0001408443","company_name":"Milestone Pharmaceuticals Inc.","filed_at":"2024-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.943727+00:00","generated_at":"2026-05-31T06:25:00.308006+00:00","sec_items":["5.02","5.07","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Milestone Pharmaceuticals appoints Joseph Papa to Board of Directors","bullets":["Joseph Papa, CEO of Emergent BioSolutions, appointed director effective Sept 3, 2024; over 35 years pharma experience.","Papa will serve on Compensation Committee; receives $42,500 annual cash retainer and 80,000-share option grant.","2024 annual meeting results: all 7 director nominees elected; PricewaterhouseCoopers ratified as auditor.","Board committees updated: Fischer named Compensation Chair; Papa joins Compensation Committee.","Company advancing CARDAMYST (etripamil nasal spray) for PSVT towards potential FDA decision."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-096648","json":"https://secwatch.observer/filing/0001104659-24-096648.json","markdown":"https://secwatch.observer/filing/0001104659-24-096648.md","text":"https://secwatch.observer/filing/0001104659-24-096648.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/0001104659-24-096648-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/tm2423263d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:25:00.308006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3213b77f0e","claim":"Joeseph C. Papa was elected as member of the Board at Milestone Pharmaceuticals Inc..","evidence_excerpt":"the Board of Directors (the “ Board ”) of Milestone Pharmaceuticals Inc. (the “ Company ”), upon the recommendation of the Nominating & Corporate Governance Committee of the Board, voted to elect Joeseph C. Papa as a member of the Board and as a member of the Board’s compensation committee (the “ Compensation Committee ”), effective as of September 3, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/0001104659-24-096648-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}